ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

CTKB vs NAUT // PIOTROSKI F-SCORE QUALITY

Cytek Biosciences Inc. (NASDAQ) VS. Nautilus Biotechnology Inc. (NASDAQ) • 15-METRIC TALLY: CTKB 4 — NAUT 0
■ METRIC PARITY
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (CTKB VS. NAUT) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC CTKB NAUT SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin 51.80% — — TIE /gross-margins <GO>
Return on Invested Capital (ROIC) -12.70% -35.00% +22.30 CTKB /roic <GO>
EV/EBITDA & P/E Valuation — — — TIE /valuation <GO>
Free Cash Flow Yield -1.07% -12.99% +11.92 CTKB /fcf-yield <GO>
Operating Margin -20.00% — — TIE /operating-margins <GO>
Net Profit Margin -33.00% — — TIE /net-margins <GO>
Revenue Growth (YoY) 0.50% — — TIE /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.00% 0.00 TIE /dividend-safety <GO>
Altman Z-Score & Debt/Equity 4.76 — — TIE /balance-sheet <GO>
Piotroski F-Score Quality ACTIVE 3/9 3/9 0.00 TIE /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 65.6 57.4 +8.20 CTKB /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — — — TIE /macro-sensitivity <GO>
Forward P/E Multiple — — — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $818.9M $399.9M $418.9M CTKB /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR CTKB REV NAUT REV CTKB GROSS % NAUT GROSS % CTKB FCF NAUT FCF
FY 2025 $201.5M $0 51.8% — -$8.8M -$52.0M
FY 2024 $200.5M $0 55.4% — $21.9M -$61.3M
FY 2023 $193.0M $0 — — $5.3M -$51.7M
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
CTKB // BETA —
NAUT // BETA —